5 Low Float Stocks With High Volume

Page 5 of 5

1. Ambrx Biopharma Inc. (NYSE:AMAM)

Number of Hedge Fund Holders: 7

Shares Float: 5.25 million

Avg Volume for 10 days: 506,000  

Ambrx Biopharma Inc. (NYSE:AMAM) is a clinical-stage biologics company that discovers and develops engineered precision biologics using its proprietary expanded genetic code technology platform. On December 9, Ambrx Biopharma stock climbed more than 150% after reporting preliminary data from a phase 2 trial of ARX788 in patients with HER2+ metastatic breast cancer who were previously treated with Roche’s Kadcyla.

On October 19, investment advisory Baird maintained an Outperform rating on Ambrx Biopharma Inc. (NYSE:AMAM) stock and lowered the price target to $4 from $8. Analyst Joel Beatty issued the ratings update. 

At the end of the third quarter of 2022, 7 hedge funds in the database of Insider Monkey held stakes worth $6.6 million in Ambrx Biopharma Inc. (NYSE:AMAM), compared to 7 the preceding quarter worth $16.6 million.

Among the hedge funds being tracked by Insider Monkey, Boston-based investment firm Cormorant Asset Management is a leading shareholder in Ambrx Biopharma Inc. (NYSE:AMAM) with 2.3 million shares worth more than $2.5 million.

You can also take a peek at 10 Best ASX Stocks To Buy and 15 Most Creative Companies in the World.

Page 5 of 5